Assisted Reproductive Technology (ART) is the technology used to achieve pregnancy in procedures such as fertility medication, in vitro fertilization and surrogacy. It is reproductive technology used primarily for infertility treatments, and is also known as fertility treatment. It mainly belongs to the field of reproductive endocrinology and infertility, and may also include intracytoplasmic sperm injection (ICSI) and cryopreservation. Some forms of ART are also used with regard to fertile couples for genetic reasons (preimplantation genetic diagnosis). ART is also used for couples who are discordant for certain communicable diseases; for example, HIV to reduce the risk of infection when a pregnancy is desired.
North America is also expected to witness growth in the coming years. This is due to people awareness towards various fertility options, government support for the in-vitro fertilization and various technological and procedure up gradation. For instance, in August 2015 Ovascience’s treatment named AUGMENT has been reported to have rejuvenated women’s aging egg cells and provided benefits to eggs with poor quality. In February 2015, the scientist of U.S. who invented the three parent IVF procedure requested the Food and Drug Administration (FDA) to grant permission for its clinical trials as age related infertility.

Market Analysis and Insights: Global Assisted Reproductive Technology (ART) Market
The global Assisted Reproductive Technology (ART) market size is projected to reach US$ 29630 million by 2027, from US$ 20050 million in 2020, at a CAGR of 5.7% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Assisted Reproductive Technology (ART) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Assisted Reproductive Technology (ART) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Assisted Reproductive Technology (ART) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Assisted Reproductive Technology (ART) market.

Global Assisted Reproductive Technology (ART) Scope and Market Size
Assisted Reproductive Technology (ART) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Assisted Reproductive Technology (ART) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
In-Vitro Fertilization (IVF)
Artificial Insemination (AI)

Segment by Application
Women Younger Than Age 35
Women Older Than Age 35

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Irvine Scientific
Origio a/s
Vitro Life
Esco Micro Pte. Ltd.
IVFtech ApS
Research Instruments
Genea Limited
Smiths Medical
Thermo Fisher Scientific, Inc.
Cook Medical